News Snapshot:
Chinese COVID-19 vaccine candidate appears safe, induces immune response, preliminary study finds Updated : November 18, 2020 11:53 AM IST Data from phase 3 studies will be crucial before any recommendations about the potential uses of CoronaVac could be made. PTI share Results from an early-phase clinical trial of a Chinese vaccine candidate, CoronaVac, revealed that the formulation appears safe and induces an antibody response in healthy volunteers aged 18 to 59 years. According to the findings of the phase 1/2 randomised clinical trial, published in The Lancet Infectious Diseases journal, the vaccine candidate could induce an antibody response in...
